Description
Composition:
Each uncoated sustained release tablet contains:
Metformin Hydrochloride IP 500mg
Mechanism:
At the molecular level, metformin inhibits the mitochondrial respiratory chain in the liver, leading to activation of AMPK, enhancing insulin sensitivity (via effects on fat metabolism) and lowering cAMP, thus reducing the expression of gluconeogenic enzymes.
Indication:
It is indicated for the treatment of Type 2 diabetes
Dosage:
Metformin hydrochloride is given at the usual starting dose of 500 mg twice daily or to be taken in a dose and duration as directed by the Physician.